LRP8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.886200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.843200E-01
Normal-vs-Stage2
3.699400E-01
Normal-vs-Stage3
5.787800E-01
Normal-vs-Stage4
8.372800E-01
Stage1-vs-Stage2
7.996800E-01
Stage1-vs-Stage3
6.162200E-01
Stage1-vs-Stage4
2.624000E-01
Stage2-vs-Stage3
6.982600E-01
Stage2-vs-Stage4
3.515200E-01
Stage3-vs-Stage4
5.952200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.922000E-01
Normal-vs-AfricanAmerican
2.193200E-01
Normal-vs-Asian
1.949570E-01
Caucasian-vs-AfricanAmerican
5.033800E-01
Caucasian-vs-Asian
7.229400E-01
AfricanAmerican-vs-Asian
4.620600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.168400E-01
Normal-vs-Female
3.308200E-01
Male-vs-Female
6.025400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.660400E-01
Normal-vs-Age(41-60Yrs)
3.424800E-01
Normal-vs-Age(61-80Yrs)
4.174000E-01
Normal-vs-Age(81-100Yrs)
3.391000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.441200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.954200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.520800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.538000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.673200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.491000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.012400E-01
Normal-vs-Daily Drinker
6.623900E-02
Normal-vs-Weekly Drinker
2.323600E-01
Normal-vs-Occasional Drinker
2.458000E-01
Normal-vs-Social Drinker
2.333800E-01
Non Drinker-vs-Daily Drinker
8.607200E-01
Non Drinker-vs-Weekly Drinker
8.847000E-01
Non Drinker-vs-Occasional Drinker
4.323200E-01
Non Drinker-vs-Social Drinker
3.284200E-01
Daily Drinker-vs-Weekly Drinker
8.013800E-01
Daily Drinker-vs-Occasional Drinker
4.840800E-01
Daily Drinker-vs-Social Drinker
4.119200E-01
Weekly Drinker-vs-Occasional Drinker
7.926800E-01
Weekly Drinker-vs-Social Drinker
7.213400E-01
Occasional Drinker-vs-Social Drinker
8.357200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.454800E-01
Normal-vs-Grade 2
4.192600E-01
Normal-vs-Grade 3
3.986800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.007000E-01
Grade 1-vs-Grade 3
3.664800E-01
Grade 1-vs-Grade 4
5.454800E-01
Grade 2-vs-Grade 3
5.945600E-01
Grade 2-vs-Grade 4
4.192600E-01
Grade 3-vs-Grade 4
3.986800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.697600E-01
Normal-vs-NonDiabetic
3.899600E-01
Diabetic-vs-NonDiabetic
8.975400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.044200E-01
Normal-vs-NoPancreatitis
4.265200E-01
Pancreatitis-vs-NoPancreatitis
8.084400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.240400E-01
Normal-vs-N1
3.670200E-01
N0-vs-N1
6.807400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.165800E-04
Normal-vs-TP53-NonMutant
1.785720E-02
TP53-Mutant-vs-TP53-NonMutant
8.257500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
